LIVEFed rate decision market screenLive market screen · BTC, gold, dollar, Nasdaq second by secondWatch

Grady Grant III, Aptevo Therapeutics option exercise

Director, SEC Form 4, filed on August 11, 2026
+400 sharesnet change in holding. Not an open-market purchase or sale
Transaction date
August 6, 2026
Shares held after
1,150Direct ownership
Change in holding
+53.33%From the transactions in the filing
Filing rows
1None is a purchase or sale

Price context

APVO daily close, Apr 8 to October 27, 2026
$5.61$1.29
Daily close
Grants, options, tax
Transaction price
Not reportedNot an open-market trade
Close on trade date
$4.07August 6, 2026
Latest close
$1.29October 27, 2026
Since the trade
−68.31%vs the close on trade date

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Option exercise
Common stockDirect
400
1,150

Recent filings at Aptevo Therapeutics

Full history
PersonTransactionAmount or sharesDate
Marvin L. WhiteChair
Tax withholdingOption exercise
+1,261 shares
Dirk HuebnerCMO
Tax withholdingOption exercise
+482 shares
Zsolt HarsanyiDirector
Option exercise
+400 shares
Barbara Lopez KunzDirector
Option exercise
+400 shares
Daniel Abdun-NabiDirector
Option exercise
+400 shares
John NiederhuberDirector
Option exercise
+400 shares
SoYoung KwonVice president
Option exercise
+638 shares
Daphne TaylorCFO
Option exercise
+638 shares